You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
和佳醫療(300273.SZ):參股公司投資的偉思醫療披露了上市發行公告
格隆匯 07-08 18:52

格隆匯 7 月 8日丨和佳醫療(300273.SZ)公佈,公司參股公司深圳市陽和生物醫藥產業投資有限公司(陽和投資)投資參股的南京偉思醫療科技股份有限公司(偉思醫療)202077日在上海證券交易所披露了首次公開發行股票並在科創板上市發行公告78日開啟申購

偉思醫療首次公開發行股票並在科創板上市發行公告偉思醫療票在上交所科創板上市,證券簡稱偉思醫療股票代碼688580”發行價67.58/股,發行新股的數量為1708.6667萬股,佔發行後偉思醫療總股本25%,發行後總股本為6834.6667萬股。

至公告披露日,公司持有陽和投資26.47%股權,陽和投資持有偉思醫350.9488萬股,佔此次發行前偉思醫療總股本的6.85%公司間接持股佔偉思醫療發行前總股本的1.81%此次發行後陽和投資持股偉思醫療總股本的5.13%公司間接持股佔偉思醫療發行後總股本的1.36%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account